For in-vitro research use only. Not for human consumption.
Retatrutide 5mg+cagrilintide 5mg
RC10 is a Nexus-only dual-incretin/amylin-pathway research blend. Component-level chemistry should come from the individual retatrutide and cagrilintide records.
Retatrutide 5mg+cagrilintide 5mg definition
RC10 is a Nexus-only dual-incretin/amylin-pathway research blend. Component-level chemistry should come from the individual retatrutide and cagrilintide records. Retatrutide 5mg+cagrilintide 5mg is classified as a multi-peptide blend. Blend of retatrutide and cagrilintide; no single molecular formula or molecular weight applies.. Supplied by Nexus Laboratory for in-vitro research use only — not approved for human or veterinary therapeutic use.
No sequence is listed in the current catalog record for this product.
- CAS
- N/A
- MW
- Not listed
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- Not listed
- Purity
- Not listed
- Form
- Lyophilized powder
- Class
- Multi-peptide blend
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- Class
- Multi-peptide blend
- Physical Form
- Lyophilized powder
- Storage
- Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Research context.
Retatrutide 5mg+cagrilintide 5mg is studied in preclinical research models examining mechanisms relevant to the glp-1, amylin, and multi-agonist metabolic research peptides. category. All Nexus Laboratory batches are documented through HPLC purity verification, mass spectrometry identity confirmation, and endotoxin screening. Compounds are supplied strictly for in-vitro and analytical research use.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
Retatrutide 5mg+cagrilintide 5mg is part of the Nexus GLP-1 & Metabolic catalog. GLP-1, amylin, and multi-agonist metabolic research peptides. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
Blend of retatrutide and cagrilintide; no single molecular formula or molecular weight applies.
Storage: Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Technical specifications.
- Product Name: Retatrutide 5mg+cagrilintide 5mg
- Classification: Multi-peptide blend
- Structural Description: Blend of retatrutide and cagrilintide; no single molecular formula or molecular weight applies.
- CAS Number: Not confirmed
- Molecular Weight: Not applicable / not confirmed
- Molecular Formula: Not applicable / not confirmed
- Physical Form: Lyophilized powder
- Intended Use: In-vitro research use only - not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
Retatrutide 5mg+cagrilintide 5mg research FAQ.
What is Retatrutide 5mg+cagrilintide 5mg used for in research?
Retatrutide 5mg+cagrilintide 5mg is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Is Retatrutide 5mg+cagrilintide 5mg HPLC verified?
Retatrutide 5mg+cagrilintide 5mg is listed with Nexus lab verification. Current catalog records show batch-specific purity context where batch COA data is available.
Which Retatrutide 5mg+cagrilintide 5mg sizes are available?
Current Nexus variants include 10mg.
Does Retatrutide 5mg+cagrilintide 5mg include a COA?
Yes. The current Nexus record links Retatrutide 5mg+cagrilintide 5mg to batch NEX-RETATRUTIDE-5MG-PLUS-CAGRILI-2026-0074.